Coronavirus Live Updates: Supreme Court slams Kerala's 'Bakrid' lockdown relaxation

·2-min read
New Delhi
Commuters take shelter near a building to shield themselves from heavy rain showers on July 19, 2021 in New Delhi. (Photo by Sonu Mehta/Hindustan Times via Getty Images)

The Supreme Court on Tuesday termed as 'wholly uncalled for' the relaxations granted by the Kerala government for the Bakrid festival in areas having the highest COVID-19 positivity rate and warned that it will take action if the easing of curbs leads to further spread of the virus.

India recorded 30,093 new coronavirus infections, the lowest in 125 days, taking the total tally of COVID cases to 3,11,74,322, according to the Health Ministry. The death toll climbed to 4,14,482 with 374 daily fatalities, the lowest in 111 days, while the active cases have declined to 4,06,130, the lowest in 117 days.

The active caseload comprises 1.30 per cent of the total infections and the national COVID-19 recovery rate stands at 97.37 per cent. A decrease of 15,535 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.

Cumulative vaccine doses administered so far has reached 41.18 crore under the nationwide vaccination drive.

India has been offered 7.5 million doses of Moderna's COVID-19 vaccine through the COVAX global vaccine sharing programme, but it is not clear when the jabs will arrive in the country as a consensus on the indemnity clause is yet to be reached. The government last week said that it is working actively with vaccine manufacturer Moderna to see how its vaccine can be made available in the country.

Moderna's COVID-19 vaccine was granted emergency use authorisation by India's drug regulator last month.

However, there is no clarity so far when the shots would be available in India as 'the talks are still on and a consensus on the indemnity issue is yet to be reached,' a source said.

On the availability of Moderna vaccine in the country, NITI Aayog member (Health) Dr V K Paul had recently said the government is working actively with Moderna to see how its vaccine can be imported and made available in the country.

According to sources, the Indian government has put forth certain conditions for finalising the indemnity clause contract and has sent it to the US drug manufacturer for their perusal.


Monkey B Virus Causes First Human Death In China; What It Is & What Are Its Symptoms

Bharat Biotech Dossier Under Review For Emergency Use Listing of Covaxin, Says WHO

COVID-19: Ivermectin, Milk Among Indonesia's Unproven Cures

Olympics 2021: What Happens If an Athlete Tests Positive For COVID-19?